HXB2 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - AIM ImmunoTech Inc

Watchlist Manager

Watchlist

Price: 0.061 EUR -41.9% Market Closed

Market Cap: €3.5m

	AIM ImmunoTech Inc F:HXB2	US
S	SF Urban Properties AG F:1Z9	CH
E	Eastgroup Properties Inc F:EGO	US
	Ferguson Enterprises Inc F:UH3	US
S	Swire Pacific Ltd OTC:SWRAY	HK
C	Cineplex Inc F:CX0	CA
A	Abercrombie & Fitch Co XMUN:AFT	US
K	Kiatnakin Phatra Bank PCL SET:KKP	TH
	Sibanye Stillwater Ltd NYSE:SBSW	ZA
D	Dominion Energy Inc XMUN:DOD	US
	Chemomab Therapeutics Ltd NASDAQ:CMMB	IL
	Aena SME SA OTC:ANNSD	ES
S	Sibanye Stillwater Ltd JSE:SSW	ZA
C	CDW Corp F:CDW	US
A	Advantest Corp XBER:VAN	JP
	Datatec Ltd F:DTT0	ZA
A	Axos Financial Inc F:BB4	US
	KSB Ltd BSE:500249	IN

Profitability Summary

AIM ImmunoTech Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-45%

Strong 3Y Average Gross Margin

63%

Declining Gross Margin

100% > -45%

Negative Operating Margin

-13.255%

Negative 3Y Average Operating Margin

-13.851%

Declining Operating Margin

-12.996% > -13.255%

Negative Net Margin

-15.861%

Negative 3Y Average Net Margin

-13.016%

Declining Net Margin

-11.514% > -15.861%

Negative Free Cash Flow Margin

-12.881%

Negative 3Y Average Free Cash Flow Margin

-10.545%

Declining Free Cash Flow Margin

-10.282% > -12.881%

Exceptional ROE

251%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-135%

ROIC is Increasing

-381% > 3.606%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.